PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Strickler, J. H.; Ou, F. S.; Bekaii-Saab, T. S.; Parseghian, C. M.; Cercek, A.; Ng, K.; Sanchez, F. A.; Bruggeman, S.; Larson, J. J.; Finley, G. G.; Hubbard, J. M.; Wu, C.; Lenz, H. J.; Kopetz, S.; Corcoran, R. B. |
| Abstract Title: | PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC) |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800002 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.TPS143 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS143 -- Source: Wos |
